SCHEMBL26712005

SCHEMBL26712005

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cccc5oc6cccc(-c7cccc8sc9c%10ccccc%10ccc9c78)c6c45)n3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 6/20 0.38
▸ CYP1B1 Q16678 5/20 0.38
▸ MAPT P10636 5/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ CYP1A2 P05177 4/20 0.33
▸ LIMK1 P53667 1/20 0.33
▸ ABCG2 Q9UNQ0 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23822040 0.95 CYP1A1 (0.37) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24193170 0.94 CYP1A1 (0.38) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24193171 0.93 CYP1A1 (0.39) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24384454 0.92 CYP1A1 (0.44) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24123248 0.92 CYP1A1 (0.44) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24123242 0.92 CYP1A1 (0.44) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24123250 0.91 CYP1A1 (0.39) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL25557624 0.90 CYP1A1 (0.43) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL24192999 0.90 CYP1A1 (0.42) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2
SCHEMBL23819374 0.89 CYP1A1 (0.38) CYP1A1CYP1B1MAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-11-02 — — US disclosed
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230354706-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, CRY1, PER2 CYP1A1 6/4885CYP1B1 25/4885MAPT 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback